Literature DB >> 8799333

Osteoblast cells (MG-63 and HOS) have aromatase and 5 alpha-reductase activities.

K Shimodaira1, H Fujikawa, F Okura, Y Shimizu, H Saito, T Yanaihara.   

Abstract

Both aromatase and 5 alpha-reductase activities were found by whole-cell assay in osteoblast-like cells, MG-63 and HOS. Aromatase activity was measured by the [3H] water release method, and the formation of 5 alpha-androstanedione from androstenedione was expressed as 5 alpha-reductase activity. When CGS16949A, an inhibitor of aromatase, was added to the incubation medium at a concentration of 2 x 10(-9) M, sufficient to completely inhibit placental aromatase activity, only 63% to 68% inhibitions were observed. When progesterone, a competitive inhibitor of 5 alpha-reductase, was added at a concentration of 10(-5) M, 28% to 40% inhibitions were recorded. Because the release of [3H] from [1 beta-3H] androstenedione into water by 5 alpha-reductase is reported, results from the present study suggest that the measurement of aromatase activity in osteoblasts by the [2H] water release method may overestimate aromatase activity owing to the inclusion of 5 alpha-reductase activity. The results also suggest that osteoblast cells may play an important role in bone metabolism by transforming androgens into estrogens and more biologically active androgen derivatives.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799333     DOI: 10.1080/15216549600201111

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  6 in total

1.  Gender aspects of osteoporosis and bone strength.

Authors:  Janina M Patsch; Julia Deutschmann; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2011-03

2.  Retaining Residual Ovarian Tissue following Ovarian Failure Has Limited Influence on Bone Loss in Aged Mice.

Authors:  Zelieann R Craig; Samuel L Marion; Janet L Funk; Mary L Bouxsein; Patricia B Hoyer
Journal:  J Osteoporos       Date:  2010-06-29

3.  Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.

Authors:  H P Ciolino; T T Wang; N Sathyamoorthy
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

4.  Antioxidative 1,4-Dihydropyridine Derivatives Modulate Oxidative Stress and Growth of Human Osteoblast-Like Cells In Vitro.

Authors:  Lidija Milkovic; Tea Vukovic; Neven Zarkovic; Franz Tatzber; Egils Bisenieks; Zenta Kalme; Imanta Bruvere; Zaiga Ogle; Janis Poikans; Astrida Velena; Gunars Duburs
Journal:  Antioxidants (Basel)       Date:  2018-09-19

5.  The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.

Authors:  Rosemary Dineen; Lucy-Ann Behan; Grainne Kelleher; Mark J Hannon; Jennifer J Brady; Bairbre Rogers; Brian G Keevil; William Tormey; Diarmuid Smith; Christopher J Thompson; Malachi J McKenna; Wiebke Arlt; Paul M Stewart; Amar Agha; Mark Sherlock
Journal:  BMC Endocr Disord       Date:  2020-10-10       Impact factor: 2.763

6.  Risk of Osteoporotic Fracture in Patients with Breast Cancer: Meta-Analysis.

Authors:  Seeyoun Lee; Jun-Il Yoo; Young-Kyun Lee; Jung-Wee Park; Seokhyung Won; Jiung Yeom; Jin Woo Im; Seok Min Lim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  J Bone Metab       Date:  2020-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.